Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Clearside Biomedical, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 66 | +14 |
| Shares | 19.7M | 111.9K | 20.3M | +703.4K (+3.6%) |
| Value | $95.8M | $545.0K | $121.5M | +$26.3M (+27.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invesco Ltd. | 277,161 | $1.66M | 0.00% |
| Franklin Resources Inc | 111,900 | $671.0K | 0.00% |
| Trexquant Investment LP | 43,768 | $263.0K | 0.02% |
| Dynamic Technology Lab Private Ltd | 39,745 | $238.0K | 0.03% |
| Jump Financial, LLC | 38,169 | $229.0K | 0.02% |
| Ameriprise Financial Inc | 38,042 | $228.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 29,360 | $176.0K | 0.00% |
| Group One Trading, L.P. | 28,202 | $169.0K | 0.00% |
| Qube Research & Technologies Ltd | 25,815 | $155.0K | 0.00% |
| ExodusPoint Capital Management, LP | 23,485 | $141.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129.0K | 0.04% |
| Assenagon Asset Management S.A. | 18,874 | $113.0K | 0.00% |
| Barclays PLC | 17,048 | $102.0K | 0.00% |
| Capstone Investment Advisors, LLC | 11,856 | $71.0K | 0.00% |
| Dorsey Wright & Associates | 9,034 | $54.0K | 0.01% |
| Citigroup Inc | 3,399 | $20.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,947 | $18.0K | 0.00% |
| Core Wealth Advisors, Inc. | 500 | $3.00K | 0.00% |
| FMR LLC | 128 | $1.00K | 0.00% |
| Federated Hermes, Inc. | 66 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Deutsche Bank AG | 104,527 | $509.0K |
| Price T Rowe Associates Inc | 37,200 | $181.0K |
| Walleye Capital LLC | 18,000 | $88.0K |
| Wolverine Trading, LLC | 15,910 | $76.0K |
| Exencial Wealth Advisors, LLC | 14,064 | $68.0K |
| Parallel Advisors, LLC | 2,000 | $10.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 111,900 | $545.0K |